4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-074964
Chief Executive Officer sold 47,775 shares at $20.03 ($956,933)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Santos da Silva Jorge Chief Executive Officer | 2026-07-01 | Sale 10b5-1 | −47,775 | $20.03 | $956,933 | 2,877,118 | D: show line 1 in the form |
| Open-market sales · 47,775 sh · avg $20.03 · $956,933 | |||||||
Loading xslF345X06/ownership.xml…